Aim immunotech inc. (HEB)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-3,808

-1,188

-2,948

-2,032

-3,365

-1,621

-3,078

-2,415

-2,713

-1,993

-1,252

-2,193

-2,821

-1,173

-2,862

-1,303

-2,164

-3,137

-3,803

-4,845

-3,445

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustments to reconcile net loss to net cash used in operating activities:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,202

-4,956

-3,836

-

-5,136

-4,283

-3,611

-5,459

-6,587

-3,000

-2,308

-3,115

-2,740

-2,294

-866

Depreciation of property and equipment

173

178

177

186

194

198

214

228

216

209

235

243

261

265

278

276

300

278

205

278

180

165

168

165

167

167

154

171

179

174

173

147

149

143

124

86

112

Amortization and abandonment of patent and trademark rights

-

-

-

-

-

-

-

-

-

15

31

4

13

59

55

40

30

83

87

8

71

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization and abandonment of patent and trademark rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

138

111

165

-

57

83

4

11

24

3

2

4

51

4

106

Redeemable warrants valuation adjustment

182

-25

-446

-1,084

45

-339

-695

-362

231

-56

-1,438

-530

-393

-1,574

-103

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of convertible note adjustment

-

-

-

-

-90

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in convertible debt - refinancing

-

-

0

0

20

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Extinguishment of convertible note

-

0

1

0

344

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant modification

46

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of patent, trademark rights

208

4

18

18

17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in ROU assets

11

11

4

11

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity-based compensation

196

204

223

251

175

178

139

326

286

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

38

-

73

30

134

122

129

133

0

0

1

22

48

Equipment acquired by capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

36

26

Unrealized loss on marketable securities

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

147

21

-

951

-1,080

36

-544

235

214

441

-692

-529

177

459

Redeemable warrants valuation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,817

1,496

85

151

-867

-2,502

1,245

-301

Redeemable warrants valuation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

102

89

-

-1,968

387

-151

-

614

643

301

Equity-based compensation

-

-

-

-

-

-

-

-

-

-

-

49

52

66

106

186

52

33

37

53

58

66

62

110

88

84

73

98

121

161

105

54

36

29

169

152

27

Realized (gain) loss on sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

31

20

-107

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of building

-

-

-

-

-

0

0

0

223

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of finance and debt issuance costs

181

-15

232

36

35

55

40

28

140

24

13

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in assets and liabilities:
Accounts and other receivables

2

758

-14

-25

-993

1,066

-7

17

-6

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

317

529

480

0

0

0

0

-

-

-

-

677

-309

0

211

-192

123

69

110

Prepaid expenses and other current assets

-49

20

17

-59

-7

21

-168

13

385

-304

19

-30

328

-250

181

15

28

57

-60

-94

33

164

-11

-87

-25

26

-27

66

-29

-

-

-

-

-

-

-

-

Lease liability

11

62

3

-36

8

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-18

-56

57

41

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-200

0

185

-185

154

-97

86

104

Accounts payable

-307

-231

-14

-49

87

-111

151

-119

245

392

89

-18

103

-124

-380

-4

182

-293

-92

-47

236

-2,083

976

254

-16

-420

829

-668

-358

-65

669

-519

775

105

459

-159

19

Accrued interest expense

143

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-117

-758

205

-256

78

417

-605

-386

-348

264

9

170

161

128

-1,618

1,341

478

-599

321

8

-844

552

-878

919

512

-594

17

536

-2,126

1,759

468

-32

-444

830

47

25

-701

Net cash used in operating activities

-3,060

-2,289

-2,544

-2,777

-1,457

-2,419

-2,976

-2,703

-2,542

-760

-1,880

-2,308

-2,993

-2,102

-2,986

-1,249

-1,043

-

-

-

-

-4,033

-3,725

-3,311

-2,895

-

-4,017

-3,778

-5,851

-4,955

-2,703

-3,813

-1,665

-3,022

-2,272

-2,984

-1,818

Cash flows from investing activities:
Proceeds from sale of marketable securities

-14,116

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits on capital leases refunded

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits on capital leases refunded

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

-1

-6

0

0

0

4

Proceeds from sale of marketable securities

-

-

-

-

-

-

-

-

-

1,100

199

1,000

500

-1

1,453

1,918

0

-

-

-

-

-

-

-

-

-

4,591

3,949

5,530

9,278

6,164

4,027

3,189

9,748

3,542

3,084

4,522

Purchase of marketable securities

10,319

5,194

209

-581

960

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,258

-1

37

-

-

0

0

-

-

-

-

7,068

-44

1

3,176

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,502

-4,980

-4,257

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment

7

0

5

49

14

-

-

-

-

0

17

0

3

0

0

160

0

14

-14

193

47

118

120

201

65

151

213

290

244

934

1,613

1,656

1,552

953

468

345

36

Proceeds from sale of building

-

-

-

-

-

0

0

0

1,050

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease deposit refund

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

0

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of patent and trademark rights

297

95

18

60

124

9

10

43

14

13

22

3

11

12

75

145

62

62

19

24

145

71

67

45

75

58

62

76

46

98

85

28

0

142

41

-96

147

Net cash provided by (used in) investing activities

3,493

-5,289

-232

472

-1,098

-1,518

617

-43

1,036

1,087

160

997

486

-27

1,390

1,613

-60

-

-

-

-

1,881

1,071

-243

-177

-

4,316

3,512

5,240

-11,004

-6,993

287

1,643

1,585

3,077

2,834

1,159

Cash flows from financing activities:
Proceeds from lease financing obligation

-

-

-

-

-

0

0

0

4,080

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance and debt issuance costs

-

-

-

-

-

-59

230

0

268

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing obligation payments

86

86

85

85

84

83

84

78

19

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payoff of mortgage note payable

-

-

-

-

-

0

0

0

-1,957

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposits paid

-

-

-

-

-

0

0

3

111

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

7

11

-

7

16

13

12

10

12

13

21

19

17

14

Proceeds from sale of stock, net of issuance costs

25,773

-4

9,618

955

4,734

166

140

2,438

2,326

237

65

1,240

875

50

4,531

161

2

1

387

4,051

5,242

3,054

1,305

2,073

6,385

249

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,438

-163

-192

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1

2

4

8

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from (payments on) Margin Account Loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,290

1,426

2,058

582

-

-

-

-

Net cash provided by financing activities

25,687

-568

11,433

870

4,650

181

2,846

2,357

4,051

582

1,001

1,757

875

64

4,531

161

1

-

-

-

-

3,046

1,299

2,066

6,374

-

-7

-16

-13

15,013

10,684

2,046

569

518

1,137

-17

-14

Net increase in cash and cash equivalents

26,120

-8,146

8,657

-1,435

2,095

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

383

4,043

5,235

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

-

-

-

-

-

-

-

-

2,545

909

-719

446

-1,632

-2,065

2,935

525

-1,102

954

-681

-1,100

786

894

-1,355

-1,488

3,302

-795

292

-282

-624

-946

988

-1,480

547

-919

1,942

-167

-673

Supplemental disclosures of non-cash investing and financing cash flow information:
Unrealized loss on marketable securities

4

-

-

-

-

-

40

-8

-12

-24

11

17

12

-20

-72

37

147

304

-215

-137

111

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

2

-2

0

-12

3

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued to settle accounts payable

10

-

-

-

-

0

50

40

240

151

641

39

67

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating Lease - Right of Use Assets

-

0

3

37

148

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of redeemable warrants granted

-

-

-

-

-

-

-

-

-

-

-

-

734

-163

2,617

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

92

-35

-44

11

20

9

6

6